Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06516653 · ClinicalTrials.gov registry record · NA

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

A NA study of End Stage Renal Disease, sponsored by Laminate Medical Technologies.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
7
Study locations

NCT06516653 is a NA study of End Stage Renal Disease that is actively recruiting participants, run by Laminate Medical Technologies. The registered enrollment target is 300 participants, below the 830-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (64% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06516653, a NA study of End Stage Renal Disease, is actively recruiting participants, sponsored by Laminate Medical Technologies.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
7
Study locations

Study Summary

VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula

Conditions Studied

End Stage Renal Disease

Interventions

  • DEVICE VasQ
  • PROCEDURE Arteriovenous fistula creation for dialysis vascular access

Study Locations (7)

California

  • Fresenius Vascular Care Long Beach - Long Beach

Florida

  • Sarasota Memorial Hospital - Sarasota

Massachusetts

  • Brigham and Women's Hospital - Boston

Mississippi

  • Greenwood Leflore Hospital - Greenwood

Nevada

  • Azura Surgery Center Las Vegas - Las Vegas

South Carolina

  • Fresenius Vascular Care Columbia - Columbia

Virginia

  • Fairlawn Surgery Center - Roanoke

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2025-01-13
Est. Completion 2028-05
Phase NA

Sponsor

Laminate Medical Technologies

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06516653

The ClinicalTrials.gov registry entry for NCT06516653 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 830-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (64% lower). The listed sponsor is Laminate Medical Technologies, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which VasQ is the first listed.

NCT06516653 reports 7 study locations spanning 7 distinct geographic areas - top geographies include California, Florida, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06516653 about?

NCT06516653 is a clinical study titled "Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula". VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported w...

What is the current status of trial NCT06516653?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-01-13. Estimated completion is 2028-05.

What conditions does trial NCT06516653 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT06516653?

The interventions under investigation include: VasQ (DEVICE), Arteriovenous fistula creation for dialysis vascular access (PROCEDURE).

Who is sponsoring clinical trial NCT06516653?

This trial is sponsored by Laminate Medical Technologies, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06516653 being conducted?

This trial has 7 study locations across California, Florida, Massachusetts, Mississippi, Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.